TY - JOUR
T1 - Cantú syndrome is caused by mutations in ABCC9
AU - Van Bon, Bregje W.M.
AU - Gilissen, Christian
AU - Grange, Dorothy K.
AU - Hennekam, Raoul C.M.
AU - Kayserili, Hülya
AU - Engels, Hartmut
AU - Reutter, Heiko
AU - Ostergaard, John R.
AU - Morava, Eva
AU - Tsiakas, Konstantinos
AU - Isidor, Bertrand
AU - Le Merrer, Martine
AU - Eser, Metin
AU - Wieskamp, Nienke
AU - De Vries, Petra
AU - Steehouwer, Marloes
AU - Veltman, Joris A.
AU - Robertson, Stephen P.
AU - Brunner, Han G.
AU - De Vries, Bert B.A.
AU - Hoischen, Alexander
PY - 2012/6/8
Y1 - 2012/6/8
N2 - Cantú syndrome is a rare disorder characterized by congenital hypertrichosis, neonatal macrosomia, a distinct osteochondrodysplasia, and cardiomegaly. Using an exome-sequencing approach applied to one proband-parent trio and three unrelated single cases, we identified heterozygous mutations in ABCC9 in all probands. With the inclusion of the remaining cohort of ten individuals with Cantú syndrome, a total of eleven mutations in ABCC9 were found. The de novo occurrence in all six simplex cases in our cohort substantiates the presence of a dominant disease mechanism. All mutations were missense, and several mutations affect Arg1154. This mutation hot spot lies within the second type 1 transmembrane region of this ATP-binding cassette transporter protein, which may suggest an activating mutation. ABCC9 encodes the sulfonylurea receptor (SUR) that forms ATP-sensitive potassium channels (K ATP channels) originally shown in cardiac, skeletal, and smooth muscle. Previously, loss-of-function mutations in this gene have been associated with idiopathic dilated cardiomyopathy type 10 (CMD10). These findings identify the genetic basis of Cantú syndrome and suggest that this is a new member of the potassium channelopathies.
AB - Cantú syndrome is a rare disorder characterized by congenital hypertrichosis, neonatal macrosomia, a distinct osteochondrodysplasia, and cardiomegaly. Using an exome-sequencing approach applied to one proband-parent trio and three unrelated single cases, we identified heterozygous mutations in ABCC9 in all probands. With the inclusion of the remaining cohort of ten individuals with Cantú syndrome, a total of eleven mutations in ABCC9 were found. The de novo occurrence in all six simplex cases in our cohort substantiates the presence of a dominant disease mechanism. All mutations were missense, and several mutations affect Arg1154. This mutation hot spot lies within the second type 1 transmembrane region of this ATP-binding cassette transporter protein, which may suggest an activating mutation. ABCC9 encodes the sulfonylurea receptor (SUR) that forms ATP-sensitive potassium channels (K ATP channels) originally shown in cardiac, skeletal, and smooth muscle. Previously, loss-of-function mutations in this gene have been associated with idiopathic dilated cardiomyopathy type 10 (CMD10). These findings identify the genetic basis of Cantú syndrome and suggest that this is a new member of the potassium channelopathies.
UR - http://www.scopus.com/inward/record.url?scp=84862128171&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2012.04.014
DO - 10.1016/j.ajhg.2012.04.014
M3 - Article
C2 - 22608503
AN - SCOPUS:84862128171
SN - 0002-9297
VL - 90
SP - 1094
EP - 1101
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 6
ER -